Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In situ sol-gel-sol transformation formed by sodium alginate realizes folic acid-modified chitosan nanoparticles to deliver hops β-acids for colorectal cancer therapy.

Journal of nanobiotechnology·2026
Same author

3D printed HAMA/GelMA/lignosulfonate hydrogel integrating oxygen-releasing and antioxidative modules for liver regeneration.

Journal of nanobiotechnology·2026
Same author

Antibacterial mechanism of hops β-acids against methicillin-resistant <i>Staphylococcus aureus</i> and promote wound healing.

Frontiers in microbiology·2025
Same author

Polysaccharide-modified liposome-based drug delivery system for cancer targeted therapy: An updated review.

International journal of biological macromolecules·2025
Same author

pH-responsive magnetic Fe<sub>3</sub>O<sub>4</sub> modified chitosan nanoparticles loaded with β-acids to improve colorectal cancer treatment.

Materials today. Bio·2025
Same author

Chitosan/PVA film containing β-acids/HP-β-CD inclusion complex for MRSA-infected wound healing.

International journal of biological macromolecules·2025

Related Experiment Video

Updated: Apr 4, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K

Animal models accurately representing acute liver failure (Review).

Sang Luo1, Fang Wu2, Yiran Jin1

  • 1Department of Beijing National Biochip Research Center Sub‑Center in Ningxia, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.

International Journal of Molecular Medicine
|April 3, 2026
PubMed
Summary

Developing accurate animal models for acute liver failure (ALF) is crucial for advancing treatments. This review evaluates existing models and proposes optimized dosages for mouse models to better simulate ALF progression.

Keywords:
acute liver failureanimal modelsdosagedrug/chemical inductionpathophysiological characteristics

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.2K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.2K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K

Area of Science:

  • Hepatology and Toxicology
  • Animal Models in Disease Research
  • Drug-Induced Liver Injury

Background:

  • Acute liver injury (ALI) is a precursor to acute liver failure (ALF), necessitating reliable animal models for research.
  • Current animal models often fail to accurately replicate the complex pathophysiology of ALF, hindering therapeutic development.
  • Mouse models are increasingly recognized for their potential in simulating ALF onset and progression.

Purpose of the Study:

  • To review the pathophysiological mechanisms of ALF.
  • To evaluate the strengths and limitations of commonly used animal models for ALF.
  • To propose optimized drug and chemical dosages for creating accurate mouse models of ALF.

Main Methods:

  • Systematic review of existing literature on ALF pathophysiology and animal models.
  • Evaluation of commonly used model organisms, focusing on mouse models.
  • Analysis of varying drug and chemical dosages employed in ALF model induction.
  • Discussion on the accuracy of ALI/ALF models concerning disease progression.

Main Results:

  • Mouse models offer significant advantages in simulating ALF onset and progression compared to other organisms.
  • Significant variability exists in drug and chemical dosages used for ALF model induction.
  • The accuracy of ALF models in reflecting disease progression is dependent on the chosen dosages.

Conclusions:

  • Optimized and standardized drug/chemical dosages are essential for developing reliable mouse models of ALF.
  • Further research into refining ALF animal models is critical for advancing therapeutic strategies.
  • Standardized mouse models will facilitate a deeper understanding of ALF pathogenesis and treatment efficacy.